Explore the words cloud of the LiverScreen project. It provides you a very rough idea of what is the project "LiverScreen" about.
The following table provides information about the project.
FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA
|Coordinator Country||Spain [ES]|
|Total cost||5˙996˙481 €|
|EC max contribution||5˙996˙481 € (100%)|
1. H2020-EU.3.1.2. (Preventing disease)
|Duration (year-month-day)||from 2020-01-01 to 2024-12-31|
Take a look of project's partnership.
|1||FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA||ES (BARCELONA)||coordinator||1˙205˙000.00|
|2||ODENSE UNIVERSITETSHOSPITAL||DK (ODENSE)||participant||650˙000.00|
|3||UNIVERSITAT DES SAARLANDES||DE (SAARBRUCKEN)||participant||649˙962.00|
|4||ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM||NL (ROTTERDAM)||participant||449˙530.00|
|5||INSTITUT CATALA DE LA SALUT||ES (BARCELONA)||participant||432˙991.00|
|6||ASSISTANCE PUBLIQUE HOPITAUX DE PARIS||FR (PARIS)||participant||340˙000.00|
|7||UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ||DE (Mainz)||participant||315˙000.00|
|8||THE UNIVERSITY OF NOTTINGHAM||UK (NOTTINGHAM)||participant||314˙000.00|
|9||UNIVERSITY COLLEGE LONDON||UK (LONDON)||participant||313˙750.00|
|10||GENESIS BIOMED||ES (BARCELONA)||participant||233˙750.00|
|11||SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET||HR (ZAGREB)||participant||225˙000.00|
|12||INNOVATION ACTA S.R.L.||IT (ROMA)||participant||221˙375.00|
|13||CONSORCIO MAR PARC DE SALUT DE BARCELONA||ES (BARCELONA)||participant||127˙372.00|
|14||BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION||ES (BARCELONA)||participant||120˙000.00|
|15||UNIVERSIDAD POMPEU FABRA||ES (BARCELONA)||participant||118˙750.00|
|16||AZIENDA OSPEDALE UNIVERSITA PADOVA||IT (PADOVA)||participant||100˙000.00|
|18||EUROPEAN LIVER PATIENTS ASSOCIATION||BE (BRUXELLES)||participant||55˙000.00|
|19||EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER||CH (ZURICH)||participant||35˙000.00|
Liver cirrhosis is a very common and severe chronic disease, responsible for high morbidity, impaired quality of life, major healthcare costs, and poor survival, causing an estimated 170,000 deaths per year in Europe. Liver cirrhosis is preceded by a long period of slowly developing, asymptomatic, liver fibrosis; most commonly caused by non-alcoholic fatty liver disease (NAFLD, related to obesity and type 2 diabetes), alcohol, and hepatitis B or C virus infection. There is no treatment available to reverse advanced liver cirrhosis. However, if fibrosis could be detected early, all of the major causes are still amenable to prevention and treatment. Early diagnosis of liver fibrosis in the general population is therefore crucial for the estimated 10 million Europeans with undetected liver fibrosis.
The LiverScreen project aims to develop a targeted screening methodology to identify persons with asymptomatic liver fibrosis and cirrhosis among the general population. This methodology involves: 1) identification of groups from the general population at high risk of having chronic liver disease, 2) screening their liver stiffness with the innovative transient elastography (TE) technology (until now only validated in patients with known liver disease) for diagnosis, and 3) determining the right follow-up screening regime. Within the LiverScreen project 8 European countries will collaborate and perform research in over 34,000 subjects to develop the screening methodology and demonstrate its accuracy, clinical value, cost-effectiveness, acceptability, and potential to be implemented by healthcare systems throughout Europe.
Using the LiverScreen program, diagnosis at an early stage can stop liver disease progression and have a subsequent long-term impact on liver disease morbidity and mortality and the associated societal burdens in terms of economic costs and health inequity. The estimated cost reduction ranges from €850 to €4,000 per quality-adjusted life-year gained.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIVERSCREEN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LIVERSCREEN" are provided by the European Opendata Portal: CORDIS opendata.
Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and EbolaRead More
European platforM to PromOte Wellbeing and HEalth in the woRkplaceRead More
Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.Read More